ArticleOncotarget2018

Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study.

Jonathan E Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.